Effects of Myofascial Chain-Based Radial Extracorporeal Shock Wave Therapy in Chronic Non-Specific Low Back Pain

Extracorporeal shock wave therapy using the myofascial chain concept for non-specific low back pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011599

Enrollment

Registered

2026-02-11

Start date

2025-06-16

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Extracorporeal shock wave therapy using the concept of myofascial chains) : Patients in the experimental group are treated with rESWT using a ShockMaster 500 (GymnaUniphy NV, Bilzen, Belgium) a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria were: (1) Adults between 18 and 70 years of age; (2) Non-specific LBP persisting for more than three months; (3) Clinically diagnosed chronic non-specific LBP characterized by recurrent lumbosacral stiffness, swelling, or pain, confirmed by either (i) X-ray findings that excluded lumbar vertebral fracture, spondylolysis, spondylolisthesis, and severe osteoporosis, or (ii) normal findings on Magnetic Resonance Imaging (MRI) or the presence of low signal intensity disc herniation; and (4) Submission of a personally signed and dated written informed consent form, indicating the patient's willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria were: (1) Individuals under 18 years or over 70 years of age; (2) Unwillingness to participate or failure to personally sign and date the written informed consent form; (3) Previous history of spinal fracture or spinal surgery; (4) Specific spinal pathology such as lumbar disc protrusion, ankylosing spondylitis, scoliosis, spondylolisthesis, or spondylolysis; (5) Presence of systemic or mental disorders; and (6) Any contraindication to radial Extracorporeal Shock Wave Therapy (rESWT), including pregnancy, the presence of blood coagulation disorders (including local thrombosis), local tumor, local bacterial or viral infection (including lumbar tuberculosis), oral anticoagulant therapy, or local corticosteroid application within six weeks prior to the first rESWT session.

Design outcomes

Primary

Measure	Time frame
Pain intensity was assessed using the Visual Analog Scale (VAS);Functional disability was evaluated using the Oswestry Disability Index (ODI)	—

Secondary

Measure	Time frame
Lumbar spine ROM was assessed using the Original Schober Test (OST)	—

Countries

Korea, Republic of

Contacts

Public ContactInseong Choi

Sahmyook University

focram07@naver.com+82-2-3399-3016

Outcome results